Drug Report History
Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.
The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.
Version v28-EN | Version v4-FR | |
---|---|---|
Language | English | French |
Date Updated | 2018-08-09 | 2018-01-05 |
Drug Identification Number | 02431130 | 02431130 |
Brand name | VINORELBINE INJECTION, USP | VINORELBINE INJECTION, USP |
Common or Proper name | 10 mg/ml Vinorelbine (as vinorelbine tartrate) | 10 mg/ml Vinorelbine (as vinorelbine tartrate) |
Company Name | GENERIC MEDICAL PARTNERS INC | GENERIC MEDICAL PARTNERS INC |
Ingredients | VINORELBINE | VINORELBINE |
Strength(s) | 10MG | 10MG |
Dosage form(s) | SOLUTION | SOLUTION |
Route of administration | INTRAVENOUS | INTRAVENOUS |
Packaging size | 5ml in clear glass vial | 5ml in clear glass vial |
ATC code | L01CA | L01CA |
ATC description | PLANT ALKALOIDS AND OTHER NATURAL PRODUCTS | PLANT ALKALOIDS AND OTHER NATURAL PRODUCTS |
Reason for shortage | Disruption of the manufacture of the drug. | Shortage of an active ingredient. |
Anticipated start date | ||
Actual start date | 2017-12-06 | 2018-01-05 |
Estimated end date | 2018-01-23 | |
Actual end date | 2018-08-01 | |
Shortage status | Resolved | Anticipated shortage |
Tier 3 Status | No | No |
Company comments | New batches of 5 ml and 1 ml have been manufactured. Contracted 5 ml demand is now being supplied on allocated. Stock levels are being increased with the manufacture of further batches of both vial sizes. | Further calcification on actual release date of new batch is being actively sought. |
Health Canada comments |